Search Results

Salbutamol/salmeterol: Dilated cardiomyopathy and fatal heart failure (first report with salmeterol): case report

Source: Reactions, Volume 1, Number 1280, 2009-11-28 , pp. 40-40(1)

Publisher: Adis International

Inhaled tiotropium bromide and risk of stroke

Authors: Grosso, Anthony; Douglas, Ian; Hingorani, Aroon D.; MacAllister, Raymond; Hubbard, Richard; Smeeth, Liam

Source: British Journal of Clinical Pharmacology, Volume 68, Number 5, November 2009 , pp. 731-736(6)

Publisher: Blackwell Publishing

Hospital and emergency department utilization associated with treatment for chronic obstructive pulmonary disease in a managed-care Medicare population

Authors: Simoni-Wastila, Linda; Keri Yang, Hui-wen; Blanchette, Christopher M.; Zhao, Lirong; Qian, Jingjing; Dalal, Anand A.

Source: Current Medical Research and Opinion, Volume 25, Number 11, November 2009 , pp. 2729-2735(7)

Publisher: Informa Healthcare

Salmeterol/fluticasone propionate: Laryngeal candidiasis: case report

Source: Reactions, Volume 1, Number 1274, 2009-10-17 , pp. 38-38(1)

Publisher: Adis International

From Antidepressant Drugs to Beta-Mimetics: Preclinical Insights on Potential New Treatments for Neuropathic Pain

Authors: Barrot, Michel; Yalcin, Ipek; Choucair-Jaafar, Nada; Benbouzid, Malika; Freund-Mercier, Marie-Jose

Source: Recent Patents on CNS Drug Discovery, Volume 4, Number 3, November 2009 , pp. 182-189(8)

Publisher: Bentham Science Publishers

Agonist efficacy and receptor desensitization: from partial truths to a fuller picture

Author: Charlton, Steven J

Source: British Journal of Pharmacology, Volume 158, Number 1, September 2009 , pp. 165-168(4)

Publisher: Blackwell Publishing

On the mechanism of the persistent action of salmeterol: what is the current position?

Author: Coleman, RA

Source: British Journal of Pharmacology, Volume 158, Number 1, September 2009 , pp. 180-182(3)

Publisher: Blackwell Publishing

Molecular mechanisms for the persistent bronchodilatory effect of the β₂-adrenoceptor agonist salmeterol

Authors: Szczuka, A; Wennerberg, M; Packeu, A; Vauquelin, G

Source: British Journal of Pharmacology, Volume 158, Number 1, September 2009 , pp. 183-194(12)

Publisher: Blackwell Publishing

The long-acting β-adrenoceptor agonist, indacaterol, inhibits IgE-dependent responses of human lung mast cells

Authors: Scola, Anne-Marie; Loxham, Matthew; Charlton, Steven J; Peachell, Peter T

Source: British Journal of Pharmacology, Volume 158, Number 1, September 2009 , pp. 267-276(10)

Publisher: Blackwell Publishing

Pharmacogenetic characterization of indacaterol, a novel β₂-adrenoceptor agonist

Authors: Sayers, I; Hawley, J; Stewart, CE; Billington, CK; Henry, A; Leighton-Davies, JR; Charlton, SJ; Hall, IP

Source: British Journal of Pharmacology, Volume 158, Number 1, September 2009 , pp. 277-286(10)

Publisher: Blackwell Publishing

Appropriate use of inhaled corticosteroid and long-acting ß₂-adrenergic agonist combination therapy among asthma patients in a US commercially insured population

Authors: Ye, Xin; Gutierrez, Benjamin; Zarotsky, Victoria; Nelson, Michael; Blanchette, Christopher M.

Source: Current Medical Research and Opinion, Volume 25, Number 9, September 2009 , pp. 2251-2258(8)

Publisher: Informa Healthcare

Evaluation of combination long-acting β-2 agonists and inhaled glucocorticosteroids for treatment of asthma

Authors: Kim, Dennis; Glaum, Mark; Lockey, Richard

Source: Expert Opinion on Drug Metabolism and Toxicology, Volume 5, Number 8, August 2009 , pp. 933-940(8)

Publisher: Informa Healthcare

Pharmacoeconomic news from ATS

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 580, 2009-06-13 , pp. 5-5(1)

Publisher: Adis International

Acute and chronic lung function responses to salmeterol and salmeterol plus fluticasone propionate in relation to Arg16Gly β₂-adrenergic polymorphisms*

Authors: Yancey, Steven W.; Klotsman, Michael; Ortega, Hector G.; Edwards, Lisa D.; Anderson, Wayne H.

Source: Current Medical Research and Opinion, Volume 25, Number 4, April 2009 , pp. 1011-1018(8)

Publisher: Informa Healthcare

Progression of chronic obstructive pulmonary disease: impact of inflammation, comorbidities and therapeutic intervention

Author: Stockley, Robert A.

Source: Current Medical Research and Opinion, Volume 25, Number 5, May 2009 , pp. 1235-1245(11)

Publisher: Informa Healthcare

Efficacy of add-on montelukast in patients with non-controlled asthma: a Belgian open-label study*

Authors: Korn, Dana; Brande, Paul Van den; Potvin, Emmanuel; Dramaix, Michèle; Herbots, Ella; Peché, Rudi

Source: Current Medical Research and Opinion, Volume 25, Number 2, February 2009 , pp. 489-497(9)

Publisher: Informa Healthcare

Healthcare use and costs in patients with chronic bronchitis initiating maintenance therapy with fluticasone/salmeterol vs other inhaled maintenance therapies

Authors: Delea, Thomas E.; Hagiwara, May; Dalal, Anand A.; Stanford, Richard H.; Blanchette, Christopher M.

Source: Current Medical Research and Opinion, Volume 25, Number 1, January 2009 , pp. 1-13(13)

Publisher: Informa Healthcare

COMPARISON OF ADHERENCE AND EFFICACY BETWEEN INHALED SALMETEROL AND TRANSDERMAL TULOBUTEROL PATCH IN ELDERLY PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISORDER

Authors: Sugawara, Tomonori; Nanjo, Yuta; Yamazaki, Mariko; Higashihara, Kazuya; Tsuda, Yasunari; Mochizuki, Hideaki; Noguchi, Toshiyuki; Takahashi, Hideki

Source: Journal of the American Geriatrics Society, Volume 57, Number 5, May 2009 , pp. 919-920(2)

Publisher: Blackwell Publishing

Salmeterol/fluticasone propionate: Achilles tendonitis (first report) following inhalation in an elderly patient: case report

Source: Reactions, Volume 1, Number 1250, 2009-05-02 , pp. 34-34(1)

Publisher: Adis International

QOL effects may be decisive for similar COPD treatments

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 578, 2009-05-16 , pp. 10-10(1)

Publisher: Adis International